Cargando…
The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes
BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become standard treatment for elderly patients with symptomatic severe aortic valve stenosis. The ACURATE neo AS study evaluates 30-day and 1-year clinical and hemodynamic outcomes in patients treated with the ACURATE neo2 valve. METHODS...
Autores principales: | Möllmann, Helge, Holzhey, David M., Hilker, Michael, Toggweiler, Stefan, Schäfer, Ulrich, Treede, Hendrik, Joner, Michael, Søndergaard, Lars, Christen, Thomas, Allocco, Dominic J., Kim, Won-Keun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639565/ https://www.ncbi.nlm.nih.gov/pubmed/34148125 http://dx.doi.org/10.1007/s00392-021-01882-3 |
Ejemplares similares
-
Transcatheter Aortic Valve Implantation with ACURATE neo: Results from the PROGRESS PVL Registry
por: Kim, Won-Keun, et al.
Publicado: (2022) -
The Early neo2 Registry: Transcatheter Aortic Valve Implantation With ACURATE
neo2 in a European Population
por: Rück, Andreas, et al.
Publicado: (2023) -
Clinical outcomes following transapical TAVR with ACURATE neo in the CHANGE neo TA study
por: Holzamer, Andreas, et al.
Publicado: (2021) -
Paravalvular Aortic Regurgitation Severity Assessed by Quantitative Aortography: ACURATE neo2 versus ACURATE neo Transcatheter Aortic Valve Implantation
por: Rück, Andreas, et al.
Publicado: (2021) -
Predictors of paravalvular leak following implantation of the ACURATE neo transcatheter heart valve: the PREDICT PVL study
por: Brinkert, Miriam, et al.
Publicado: (2020)